- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02851927
Mini Thoracoscopy vs Semirigid Thoracoscopy in Exudative Pleural Effusions (MIST)
Rigid 'Mini-thoracoscopy' vs Semirigid Thoracoscopy in Undiagnosed Exudative Pleural Effusions : A Randomized Controlled Trial
Undiagnosed pleural effusion is a diagnostic dilemma especially in exudative pleural effusions (EPE). 20-40 % are unable to be attributed to a specific diagnosis, even after thoracentesis and closed pleural biopsy. Thoracoscopy has been demonstrated to increase the diagnostic yield in undiagnosed EPE. The diagnostic yield of thoracoscopy in malignant and TB pleural effusion ranges from 91% to 94% and 93% to 100%, respectively.
Rigid thoracoscopy has traditionally been the modality of choice. The recently introduced semirigid thoracoscope provides ease of handling like a flexible bronchoscope. However, there are concerns about the diagnostic yield of semi-rigid thoracoscopy when compared with rigid thoracoscopy. According to the available literature, the yield of semirigid and rigid thoracoscopy is almost similar if adequate pleural biopsy is obtained. However there are concerns that with semi-rigid thoracoscope, there might be greater incidence of inability to obtain adequate pleural biopsy. On the other hand, the use of conventional rigid thoracoscope may be associated with greater procedure related pain.Mini-Thoracoscopy is a newer rigid thoracoscopy instrument which is smaller in diameter (5.5 mm) and may allow pleural biopsy with a smaller incision. There is scant literature on its utility. The investigators hereby propose to undertake a randomized comparison of rigid 'mini thoracoscope' vs semi rigid thoracoscope in undiagnosed pleural effusions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients meeting the inclusion criteria and giving prior consent for the study shall be randomised. The randomization sequence will be computer generated with variable block size and the assignments will be placed in opaque sealed envelopes. All patients will undergo hemogram, liver and renal function tests, coagulation profile, an electrocardiogram and Computed tomography (CT) of the chest before entering the study. Chest ultrasound will be performed in all patients to evaluate the rib spaces, amount of pleural fluid and for selection of the entry point.
Instruments The semi-rigid thoracoscope to be used is the autoclavable Olympus LTF-160 (Olympus, Tokyo, Japan) thoracoscope with 2.8 mm inner channel diameter and 7 mm outer diameter. The forceps is flexible forceps with alligator jaw with spike cusps, 2.8 mm of the outer diameter. The rigid mini thoracoscope is the Richard Wolf 5.5 mm operating endoscope with the working channel.
Thoracoscopy technique Thoracoscopy will be performed in the interventional pulmonology lab. Patients shall be fasting for solids for 8 hours and for liquids 6 hours. Patients shall be having continuous monitoring of blood pressure, pulse rate, and oxygen saturation.
Topical anesthesia will be achieved by infiltrating 2% lidocaine locally at the incision site. The procedure shall be performed under conscious sedation and analgesia using a combination of midazolam and intravenous fentanyl. An incision shall be made at the site of maximum fluid thickness as assessed by pre-procedural USG chest, with the patient in lateral decubitus position and involved side upward. After incision, the appropriately sized trocar shall be placed through the skin into the pleural space. The thoracoscope shall be inserted through the trocar. The pleural surfaces shall then be thoroughly inspected. A minimum of 6-8 pleural biopsy samples shall be obtained by semi-rigid thoracoscope and at least 4 with rigid mini-thoracoscope.
Samples shall be sent for histopathological analysis and mycobacterial cultures. At the end of the procedure, a chest tube shall be placed and removed subsequently.
All patients shall be followed up for a period of six months from the time of procedure if non-specific inflammation/ fibrinous pleuritis is the diagnosis or no definitive diagnosis is made during that time.
Statistical analysis:
Data shall be expressed as mean ± standard deviation (SD), or percentage. Differences in continuous variables between the two groups shall be compared using Student's t test (or Mann-Whitney U test); while differences in categorical data shall be compared using the chi-square test (or Fisher's exact test). A p value of less than 0.05 shall be considered statistically significant.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
New Delhi, India, 110029
- All India Institute of Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age >18 years Presence of undiagnosed exudative pleural effusion as determined by the criteria detailed by Light et al where a specific diagnosis was not obtained after initial cytological and/or microbiological examinations.
Adequate rib spaces for successful performance of thoracoscopy as judged by clinical examination Adequate pleural fluid space as judged by pre-procedural USG chest
Exclusion Criteria:
- Pregnancy
- Coagulopathy (platelet count < 50000/mm3, INR > 1.5)
- Unstable hemodynamic status ( SBP > 180, DBP> 100 or SBP< 90 mm Hg / heart failure
- Myocardial infarction or unstable angina in the last 6 wk
- Hypoxemia not correctable with low flow oxygen (SpO2 <90% despite low flow oxygen @ 1-2 l/min)
- Extensive rib crowding as judged by clinical examination
- Extensive adhesions and lack of pleural space on USG chest
- Refusal of consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mini Thoracoscopy
Thoracoscopy procedure shall be performed using the Rigid Mini Thoracoscope
|
Pleural biopsy using rigid mini thoracoscope
|
|
Active Comparator: Semirigid Thoracoscopy
Thoracoscopy procedure shall be performed using the SemiRigid Thoracoscope
|
Pleural biopsy using semirigid thoracoscope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic Yield
Time Frame: Through study completion, an average of 1 year
|
Proportion of diagnostic biopsies in the two arms
|
Through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sedation dose
Time Frame: Through study completion, an average of 1 year
|
Comparison of sedative and analgesic agent doses between the two groups
|
Through study completion, an average of 1 year
|
|
Complications
Time Frame: Through study completion, an average of 1 year
|
Complications related to the procedure
|
Through study completion, an average of 1 year
|
|
Procedural pain
Time Frame: Through study completion, an average of 1 year
|
Patient rated procedural pain on Visual Analogue Scale
|
Through study completion, an average of 1 year
|
|
Operator rated pain
Time Frame: Through study completion, an average of 1 year
|
Operator rated procedural pain on Visual Analogue Scale
|
Through study completion, an average of 1 year
|
|
Operator rated overall procedure satisfaction
Time Frame: Through study completion, an average of 1 year
|
Operator rated overall procedure satisfaction on Visual Analogue Scale
|
Through study completion, an average of 1 year
|
|
Biopsy Size
Time Frame: Through study completion, an average of 1 year
|
Mean size of biopsy obtained during pleural biopsy procedure
|
Through study completion, an average of 1 year
|
|
Alternate equipment
Time Frame: Through study completion, an average of 1 year
|
Requirement of conversion to alternate equipment for pleural biopsy
|
Through study completion, an average of 1 year
|
|
Image quality
Time Frame: Through study completion, an average of 1 year
|
Operator rated image quality of pleural visualization (VAS)
|
Through study completion, an average of 1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ease of biopsy
Time Frame: Through study completion, an average of 1 year
|
Ease of obtaining pleural biopsy on visual analogue scale
|
Through study completion, an average of 1 year
|
|
Operator rated pain on scope manipulation
Time Frame: Through study completion, an average of 1 year
|
Operator rated pain on scope manipulation on Visual analogue scale (VAS)
|
Through study completion, an average of 1 year
|
|
Expectation of diagnostic biopsy
Time Frame: Through study completion, an average of 1 year
|
Expectation that biopsy will be diagnostic on Visual Analogue Scale
|
Through study completion, an average of 1 year
|
|
Ease of manoeuvring thoracoscope
Time Frame: Through study completion, an average of 1 year
|
Ease of scope maneuvering on Visual Analogue Scale
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
Investigators
- Study Chair: Randeep Guleria, MD, DM, AIIMS, New Delhi
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Mini vs Semirigid RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Effusion
-
Assiut UniversityNot yet recruitingPleural Effusion | Exudative Pleural Effusion | Transudative Pleural Effusion
-
China-Japan Friendship HospitalNot yet recruiting
-
Ain Shams UniversityCompletedThoracoscopy | Pleural Effusion DisorderEgypt
-
Oregon Health and Science UniversityThe Gerber FoundationCompletedChylous Pleural Effusion Following Cardiothoracic SurgeryUnited States
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
Sheng HuWuhan Binhui Biotechnology Co., Ltd.RecruitingMalignant Pleural Effusion | Malignant Peritoneal EffusionChina
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia
-
Assiut UniversityNot yet recruitingMalignant Pleural EffusionEgypt
-
JemincareZhejiang Hangyu Pharmaceutical Co., LtdRecruitingMalignant Pleural EffusionChina
-
National University of Ireland, Galway, IrelandRecruitingMalignant Pleural EffusionIreland
Clinical Trials on Mini Thoracoscopy
-
Postgraduate Institute of Medical Education and...RecruitingPleural EffusionIndia
-
Naestved HospitalOdense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark and other collaboratorsTerminated
-
China-Japan Friendship HospitalNot yet recruitingPleural Effusion Disorder
-
Alexandria UniversityCompleted
-
Assiut UniversityUnknown
-
China-Japan Friendship HospitalNot yet recruitingPleural Effusion, Malignant | Pleural Effusion | Fibrinous Pleuritis
-
Ain Shams UniversityCompletedThoracoscopy | Pleural Effusion DisorderEgypt
-
E-DA HospitalUnknownPulmonary Nodules | Video-assisted Thoracic SurgeryTaiwan
-
Hopital FochCompletedMyelopathy | Giant Thoracic HerniationFrance
-
National Cancer Center, KoreaUnknownCarcinoma, Non-Small-Cell Lung | Thoracic Surgery, Video-AssistedKorea, Republic of